Center-Authored Papers

Filters: Author is Karim, Salim Abdool  [Clear All Filters]
2016
Gray GE, Laher F, Doherty T, Karim SA, Hammer S, Mascola J, Beyrer C, Corey L.  2016.  Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS? PLoS biology. 14(3):e1002372. Abstract
Rademeyer C, Korber B, Seaman MS, Giorgi EE, Thebus R, Robles A, Sheward DJ, Wagh K, Garrity J, Carey BR et al..  2016.  Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization.. PLoS pathogens. 12(7):e1005742. Abstract
2014
Guffey BM, Richardson B, Husnik M, Makanani B, Chilongozi D, Yu E, Ramjee G, Mgodi N, Gomez K, Hillier SL et al..  2014.  HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women.. Sexually transmitted infections. Abstract
Seaton KE, Ballweber L, Lan A, Donathan M, Hughes S, Vojtech L, Moody AM, Liao H-X, Haynes BF, Galloway CG et al..  2014.  HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities.. PloS one. 9(7):e101863. Abstract
2013
Richardson BA, Kelly C, Ramjee G, Fleming T, Makanani B, Roberts S, Musara P, Mkandawire N, Moench T, Coletti A et al..  2013.  Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: A comparison of the two control arms of HPTN 035.. Journal of acquired immune deficiency syndromes (1999). Abstract